SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Zvi Yammer who wrote (1025)2/5/1998 7:12:00 AM
From: Howard Frederick  Respond to of 2742
 
//
My guess is that CIST is working out a deal with Dr. Grausz.

Probably trying to recover 250+k owed to it at teh 10 cents a share
that Cist offered Med-Tech.
//

I hope you are right. IMHO, Galton has not received nearly as much
credit for the previous buy back as he deserves. Also, IMHO, he should buy back all the stock he can at .10. (Yes, I am aware that the previous buyback had no lifting effect on the stock price. Enough of these will have an impact on the stock price.)

I own some shares of CIST stock.



To: Zvi Yammer who wrote (1025)2/5/1998 10:44:00 AM
From: Steve Harmon  Read Replies (1) | Respond to of 2742
 
Look for the periodontal news to be VERY positive. Cistron has been holding it back for several months now. If it was negative they would have released it last year.

Told the shareholders at the annual meeting the results would be released by the end of January? Heavy accumulation the last few trading sessions is a good sign.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News